Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy
Phase 3 Completed
236 enrolled 28 charts
Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery
Phase 2 Completed
21 enrolled 17 charts
TH V THL
Phase 3 Completed
75 enrolled
TOUCH
Phase 2 Completed
147 enrolled 11 charts
METEORA-II
Phase 2 Completed
140 enrolled 11 charts
Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
Phase 1/2 Completed
88 enrolled
Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer
Phase 2 Completed
275 enrolled 13 charts
Nab-Paclitaxel to Paclitaxel in Advanced Urothelial Cancer Progressing on or After Platinum Containing Regimen.
Phase 2 Completed
199 enrolled 14 charts
AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)
Phase 1 Completed
50 enrolled
Paclitaxel + Carboplatin With/Out Cediranib Maleate in Stage III or Stage IV Non-Small Cell Lung Cancer
Phase 2/3 Completed
296 enrolled
A Study of Reolysin For Patients With Advanced/Metastatic Breast Cancer
Phase 2 Completed
81 enrolled
Study of Selumetinib in Patients With Previously Treated or Untreated Advanced/Metastatic NSCLC
Phase 1 Completed
39 enrolled
Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer
Phase 2 Completed
37 enrolled 8 charts
BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase 2 Completed
70 enrolled 10 charts
Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer
Phase 2 Completed
39 enrolled 7 charts
Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma
Phase 2 Completed
46 enrolled 7 charts
Cetuximab, Chemotherapy, and Radiation Therapy for Operable Stage III or IV Head and Neck Cancer
Phase 2 Completed
74 enrolled 8 charts
Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer
Phase 2 Completed
97 enrolled 9 charts
Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach
Phase 2 Completed
55 enrolled
Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium
Phase 3 Completed
330 enrolled
Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors
Phase 2 Completed
44 enrolled
Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer
Phase 3 Completed
230 enrolled
Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function
Phase 2 Completed
Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Phase 2 Completed
Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer
Phase 2 Completed
22 enrolled
Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer
Phase 2 Completed
32 enrolled
Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma
Phase 2 Completed
33 enrolled
Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer
Phase 2 Completed
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Can Not Be Surgically Removed
Phase 3 Completed
294 enrolled
Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
Phase 2 Completed
Combination Chemotherapy in Treating Patients With Bladder Cancer
Phase 3 Completed
490 enrolled
Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes
Phase 3 Completed
Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer
Phase 2 Completed
Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer
Phase 2 Completed
Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase 3 Completed
722 enrolled
Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer
Phase 2 Completed
36 enrolled
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
Phase 3 Completed
926 enrolled 13 charts
NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)
Phase 3 Completed
377 enrolled
High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase 3 Completed
544 enrolled 21 charts
Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
Phase 3 Completed
344 enrolled 11 charts
Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer
Phase 2 Completed
141 enrolled 16 charts
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
Phase 3 Completed
1,381 enrolled 12 charts
Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer
Phase 2 Completed
50 enrolled 14 charts
Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
Phase 3 Completed
2,130 enrolled
Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer
Phase 3 Completed
397 enrolled 11 charts
Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer
Phase 3 Completed
Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
Phase 3 Completed
21 enrolled
Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer
Phase 2 Completed
Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer
Phase 2/3 Completed
774 enrolled
Combination Chemotherapy Regimens in Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Phase 3 Completed
819 enrolled